Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 1, 2001, Pages 115-121

  Perkins, A C ^a   Wilson, C G ^b   Frier, M ^a   Blackshaw, P E ^a   Juan, D ^c   Dansereau, R J ^d   Hathaway, S ^d   Li, Z ^d   Long, P ^d   Spiller, R C ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c Procter and Gamble Pharmaceuticals ^*  (United States)

^d PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISEDRONIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COATING; ESOPHAGITIS; FEMALE; GAMMA SCINTIGRAPHY; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE TRANSIT TIME; MALE; PAGET BONE DISEASE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; STOMACH EMPTYING; TABLET DISINTEGRATION TIME;

EID: 0035176679     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00865.x     Document Type: Article

References (21)

1. Pamidronate: An unrecognized problem in gastrointestinal tolerability
2. Esophagitis associated with the use of alendronate
3. Alendronate use among 812 women: Prevalence of gastrointestinal complaints, non-compliance with patient instructions and discontinuation
4. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations
5. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease
6. Evaluation of methods for qualitative and quantitative assessment of esophageal transit of liquid
7. Computer analysis of radionuclide oesophageal transit studies
8. The bolus transport diagram: A functional display method applied to oesophageal studies
9. Validation of scintigraphy for monitoring the in vivo release of oral pharmaceutical formulations
10. The investigation of gastroesophageal reflux disease
11. Effect of peristaltic dysfunction on esophageal volume clearance
12. Impaired esophageal emptying in reflux disease
13. Esophageal peristaltic dysfunction in peptic esophagitis
14. Reflux eosophagitis and oesophageal transit: Evidence for a primary eosophageal motor disorder
15. Does delayed gastric emptying contribute to gastroesophageal reflux disease?
16. Gastric emptying in patients with gastroesophageal reflux
17. Gastrin, gastric emptying, and gastroesophageal reflux after ranitidine
18. Esophageal scintigraphy: Reproducibility and normal ranges
19. Gastric emptying in normal subjects - A reproducible technique using a single scintillation camera and computer system
20. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
21. The effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis